Mutagenicity in urine from nurses handling cytostatic agents

Area of Science:

• Occupational Health
• Toxicology
• Genetics

Background:

• Cytostatic drugs are widely used in chemotherapy.
• Occupational exposure to cytotoxic agents poses potential health risks to healthcare professionals.
• Assessing the genotoxic effects of occupational exposure is crucial for worker safety.

Purpose of the Study:

• To investigate the mutagenic activity in the urine of nurses handling cytostatic drugs.
• To compare mutagenicity levels between nurses, matched controls, and chemotherapy patients.
• To identify specific drug handling practices associated with increased mutagenicity.

Main Methods:

• A cohort study involving 29 nurses, 29 matched controls, and 7 chemotherapy patients.
• Urinary mutagenicity assays using the Ames test with Salmonella typhimurium strains (TA 98, TA 100, TA 1535) with and without S9 mix.
• Adjustment for smoking habits and comparison between nurses handling electrophilic and non-electrophilic drugs.

Main Results:

• Significantly higher mutagenic activity was observed in patients undergoing chemotherapy compared to controls.
• Nurses handling cytostatic drugs exhibited a significant increase in urinary mutagenic activity compared to matched controls (P < 0.05).
• Nurses handling electrophilic cytostatic agents showed significantly higher mutagenicity than those handling non-electrophilic agents (P < 0.05).

Conclusions:

• Occupational handling of cytostatic drugs is associated with increased urinary mutagenicity in nurses.
• Exposure to electrophilic cytostatic agents may pose a higher genotoxic risk.
• These findings highlight the need for stringent safety measures to minimize exposure in healthcare settings.